They’re non-invasive with none of the dreaded prep. But are recently approved home tests for colon cancer as effective as ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Colon Cancer. According to GlobalData, Phase II drugs for Colon Cancer have an 11% phase transition success rate (PTSR) ...

[23] The mechanisms that underlie the protective effect of estrogens on colorectal carcinogenesis are not completely understood, although both direct effects on the ERs expressed in colonocytes ...

may promote inflammation and potentially contribute to colon cancer development. 'The concern is primarily with oxidized forms of these oils, which are created during high-heat cooking.' ...

The team found that the mice with Alzheimer's were less likely to develop colorectal cancer. Next, the researchers gave mice with Alzheimer's symptoms stool transplants from healthy mice and then ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to ...

Biocytogen’s fully human antibody will support the development of SOT109, SOTIO’s new ADC candidate aimed at the treatment of colorectal cancer and other gastrointestinal (GI) cancers.

and The University of Texas MD Anderson Cancer Center ("MD Anderson”), today announced a worldwide exclusive license agreement and clinical trial agreement to develop and advance AmMax's AMB-066 ...